CanSino Biologics, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-395.00
-2,188.00
-1,376.00
2,334.00
-445.00
-177.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-125.00
-161.00
-1,719.00
101.00
-113.00
-14.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-251.00
-1,077.00
-2,125.00
2,466.00
-502.00
-188.00
Cash Flow from Investing Activities
4.00
-487.00
-1,510.00
-2,376.00
-237.00
-919.00
Cash Flow from Financing Activities
-293.00
69.00
1,048.00
1,168.00
5,540.00
1,246.00
Net Cash Inflow / Outflow
-531.00
-1,474.00
-2,400.00
1,216.00
4,769.00
163.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
9.00
22.00
186.00
-40.00
-30.00
24.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of CanSino Biologics, Inc.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-395.13020026853
19.3981615355212
-414.00
-2136.95%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-125.133526335466
-61.8306645243244
-64.00
-102.38%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-251.747018215956
273.142656697877
-524.00
-192.17%
Cash Flow from Investing Activities
4.29569486401979
-330.018440862162
334.00
101.30%
Cash Flow from Financing Activities
-293.177379685902
-29.432769634749
-264.00
-896.09%
Net Cash Inflow / Outflow
-531.179692250374
-70.9679320859074
-461.00
-648.48%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
9.44901078746402
15.3406217131274
-6.00
-38.41%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 76.64% vs 49.30% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-251.75
-1,077.56
76.64%






